Pacira Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Pacira BioSciences
PCRX Stock  USD 25.32  0.00  0.00%   
Pacira BioSciences' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Pacira BioSciences' valuation are provided below:
Gross Profit
470.7 M
Profit Margin
0.0299
Market Capitalization
1.1 B
Enterprise Value Revenue
1.7178
Revenue
716.8 M
We have found one hundred twenty available trending fundamental ratios for Pacira BioSciences, which can be analyzed and compared to other ratios and to its competitors. All investors should make sure to check out all of Pacira BioSciences recent market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. Market Cap is likely to rise to about 1.7 B in 2026. Enterprise Value is likely to rise to about 1.8 B in 2026

Pacira BioSciences Total Revenue

846.42 Million

Check Pacira BioSciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pacira BioSciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 95.1 M, Interest Expense of 15.3 M or Selling General Administrative of 147.4 M, as well as many indicators such as Price To Sales Ratio of 1.36, Dividend Yield of 0.0014 or PTB Ratio of 1.22. Pacira financial statements analysis is a perfect complement when working with Pacira BioSciences Valuation or Volatility modules.
  
Build AI portfolio with Pacira Stock
Check out the analysis of Pacira BioSciences Correlation against competitors.
For more information on how to buy Pacira Stock please use our How to Invest in Pacira BioSciences guide.

Pacira BioSciences Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets1.9 B1.8 B913.1 M
Slightly volatile
Other Current Liabilities50 M92.1 M53.2 M
Slightly volatile
Total Current Liabilities374.2 M356.4 M165.1 M
Slightly volatile
Total Stockholder Equity939.9 M895.1 M431.5 M
Slightly volatile
Other Liabilities24.9 M43.5 M25.5 M
Slightly volatile
Property Plant And Equipment Net127.2 M248.8 M135.2 M
Slightly volatile
Current Deferred Revenue41.1 M39.1 M25.2 M
Slightly volatile
Accounts Payable23.1 M22 M11.9 M
Slightly volatile
Cash334.2 M318.3 M153.2 M
Slightly volatile
Non Current Assets Total976.1 M929.6 M484.6 M
Slightly volatile
Non Currrent Assets Other8.5 M7.1 M8.4 M
Slightly volatile
Other Assets1.091.1536.1 M
Pretty Stable
Cash And Short Term Investments585.2 M557.3 M297.2 M
Slightly volatile
Net Receivables136.8 M130.3 M56 M
Slightly volatile
Common Stock Total Equity32.8 K51.8 K37.4 K
Slightly volatile
Common Stock Shares Outstanding36.8 M53.2 M37.7 M
Slightly volatile
Short Term Investments143.3 M239 M152.6 M
Slightly volatile
Liabilities And Stockholders Equity1.9 B1.8 B913.1 M
Slightly volatile
Non Current Liabilities Total287 M535 M300.4 M
Slightly volatile
Inventory151.3 M144.1 M63.9 M
Slightly volatile
Other Current Assets26.5 M25.2 M12.8 M
Slightly volatile
Other Stockholder Equity620.3 M1.1 B655.6 M
Slightly volatile
Total Liabilities936 M891.4 M481.6 M
Slightly volatile
Property Plant And Equipment Gross421.8 M401.7 M177.3 M
Slightly volatile
Total Current Assets899.7 M856.9 M428.5 M
Slightly volatile
Short Term Debt254.4 M242.3 M102.9 M
Slightly volatile
Intangible Assets514.4 M489.9 M206.4 M
Slightly volatile
Common Stock36 K54 K37.9 K
Slightly volatile
Property Plant Equipment307.2 M292.5 M145.1 M
Slightly volatile
Short and Long Term Debt Total372.1 M734.7 M363.6 M
Slightly volatile
Long Term Debt Total240.7 M360 M212.9 M
Slightly volatile
Capital Surpluse685.2 M1.1 B664.3 M
Slightly volatile
Non Current Liabilities Other36.4 M42.6 M29.3 M
Slightly volatile
Short and Long Term Debt243.6 M232 M94.6 M
Slightly volatile
Net Invested Capital1.1 B1.6 B868.6 M
Slightly volatile
Net Working Capital411.8 M500.5 M367.7 M
Slightly volatile
Capital Stock48.9 K54 K43.6 K
Slightly volatile
Capital Lease Obligations52.7 M48.2 M53.5 M
Slightly volatile

Pacira BioSciences Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization95.1 M90.6 M34.2 M
Slightly volatile
Interest Expense15.3 M19.1 M15.4 M
Slightly volatile
Selling General Administrative147.4 M140.4 M74.8 M
Slightly volatile
Total Revenue846.4 M806.1 M387.6 M
Slightly volatile
Other Operating Expenses935 M890.5 M397.3 M
Slightly volatile
Research Development49.2 M93.8 M50.5 M
Slightly volatile
Cost Of Revenue205.8 M196 M110.3 M
Slightly volatile
Total Operating Expenses729.2 M694.5 M287 M
Slightly volatile
Non Recurring2.4 M2.7 M3 M
Slightly volatile
Selling And Marketing Expenses113 M197.8 M100.4 M
Slightly volatile
Interest Income23.8 M22.6 M8.7 M
Slightly volatile
Reconciled Depreciation46.4 M90.6 M33.6 M
Slightly volatile

Pacira BioSciences Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation61.8 M58.8 M32.7 M
Slightly volatile
Begin Period Cash Flow94.5 M176.3 M100.7 M
Slightly volatile
Depreciation95.1 M90.6 M34.2 M
Slightly volatile
Capital Expenditures21.1 M12.2 M20.5 M
Pretty Stable
End Period Cash Flow334.2 M318.3 M138.2 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.361.436.6188
Slightly volatile
Dividend Yield0.00140.00120.0018
Slightly volatile
PTB Ratio1.221.297.4664
Slightly volatile
Days Sales Outstanding37.9953.149.0084
Very volatile
Book Value Per Share15.9115.1510.3204
Slightly volatile
Stock Based Compensation To Revenue0.07130.06570.0951
Slightly volatile
Capex To Depreciation0.150.161.3881
Slightly volatile
PB Ratio1.221.297.4664
Slightly volatile
Inventory Turnover1.491.563.1061
Slightly volatile
Days Of Inventory On Hand125241171
Slightly volatile
Payables Turnover7.228.029.7046
Pretty Stable
Sales General And Administrative To Revenue0.320.20.3465
Slightly volatile
Research And Ddevelopement To Revenue0.130.11640.3301
Slightly volatile
Capex To Revenue0.01660.01740.1306
Slightly volatile
Cash Per Share9.0912.058.6831
Very volatile
Days Payables Outstanding76.6347.1254.1671
Slightly volatile
Intangibles To Total Assets0.150.250.1885
Slightly volatile
Current Ratio2.552.163.3007
Pretty Stable
Receivables Turnover8.97.117.7099
Very volatile
Shareholders Equity Per Share15.9115.1510.3204
Slightly volatile
Capex Per Share0.250.261.151
Slightly volatile
Revenue Per Share8.0113.649.6934
Slightly volatile
Interest Debt Per Share6.5312.768.8213
Slightly volatile
Debt To Assets0.310.370.3811
Pretty Stable
Graham Number13.7517.6516.679
Slightly volatile
Operating Cycle163295220
Slightly volatile
Price Book Value Ratio1.221.297.4664
Slightly volatile
Days Of Payables Outstanding76.6347.1254.1671
Slightly volatile
Company Equity Multiplier1.631.82.4372
Slightly volatile
Quick Ratio2.211.82.8418
Very volatile
Net Income Per E B T1.171.421.4092
Pretty Stable
Cash Ratio1.221.031.1223
Pretty Stable
Days Of Inventory Outstanding125241171
Slightly volatile
Days Of Sales Outstanding37.9953.149.0084
Very volatile
Price To Book Ratio1.221.297.4664
Slightly volatile
Fixed Asset Turnover1.692.922.2962
Slightly volatile
Debt Ratio0.310.370.3811
Pretty Stable
Price Sales Ratio1.361.436.6188
Slightly volatile
Asset Turnover0.340.410.4287
Very volatile
Price Fair Value1.221.297.4664
Slightly volatile

Pacira BioSciences Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap1.7 B1.6 B1.5 B
Slightly volatile

Pacira Fundamental Market Drivers

Forward Price Earnings7.0274
Cash And Short Term Investments484.6 M

Pacira Upcoming Events

27th of February 2024
Upcoming Quarterly Report
View
1st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
27th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Pacira BioSciences Financial Statements

Pacira BioSciences investors use historical fundamental indicators, such as Pacira BioSciences' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Pacira BioSciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue39.1 M41.1 M
Total Revenue806.1 M846.4 M
Cost Of Revenue196 M205.8 M
Stock Based Compensation To Revenue 0.07  0.07 
Sales General And Administrative To Revenue 0.20  0.32 
Research And Ddevelopement To Revenue 0.12  0.13 
Capex To Revenue 0.02  0.02 
Revenue Per Share 13.64  8.01 
Ebit Per Revenue(0.09)(0.10)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
JBLJabil Circuit
MRKMerck Company
AMGNAmgen Inc

Additional Tools for Pacira Stock Analysis

When running Pacira BioSciences' price analysis, check to measure Pacira BioSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pacira BioSciences is operating at the current time. Most of Pacira BioSciences' value examination focuses on studying past and present price action to predict the probability of Pacira BioSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pacira BioSciences' price. Additionally, you may evaluate how the addition of Pacira BioSciences to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY